|
|
Volumn 101, Issue 3, 2009, Pages 138-139
|
|
Agents targeting apoptosis show promise in early trials
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1 (2 METHOXYETHOXY) 2 METHYL 3 (2 PYRAZINYLMETHYL)NAPHTHO[2,3 D]IMIDAZOLE 4,9 DIONE;
ANTINEOPLASTIC AGENT;
APOPTOSIS REGULATORY PROTEIN;
BIRC5 PROTEIN, HUMAN;
IMIDAZOLE DERIVATIVE;
MICROTUBULE ASSOCIATED PROTEIN;
NAPHTHOQUINONE;
PROTEIN BAX;
TUMOR MARKER;
APOPTOSIS;
CLINICAL TRIAL;
DRUG ANTAGONISM;
DRUG EFFECT;
HUMAN;
METABOLISM;
NOTE;
SIGNAL TRANSDUCTION;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
APOPTOSIS;
APOPTOSIS REGULATORY PROTEINS;
BCL-2-ASSOCIATED X PROTEIN;
CLINICAL TRIALS AS TOPIC;
HUMANS;
IMIDAZOLES;
MICROTUBULE-ASSOCIATED PROTEINS;
NAPHTHOQUINONES;
SIGNAL TRANSDUCTION;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 61549141682
PISSN: 00278874
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djn507 Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|
